Self-sampling for Non-attenders to Cervical Cancer Screening

Launched by THE INSTITUTE OF MOLECULAR AND TRANSLATIONAL MEDICINE, CZECH REPUBLIC · Jan 9, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a new way to encourage women in the Czech Republic to participate in cervical cancer screening. It focuses on whether self-sampling, where women can collect their own samples for testing, along with human papillomavirus (HPV) testing, can help increase the number of women getting screened. The trial will look at different methods of providing these self-sampling devices to see which works best.

To be eligible for this trial, women should be between the ages of 30 and 65, or older than 65 for one specific group. They must have lived in the Czech Republic and have not participated in cervical cancer screening for at least three years. Participants will need to provide their consent and should be comfortable taking a sample themselves. However, pregnant women, those with no sexual experience, and women who have had a hysterectomy (removal of the uterus) are not eligible. If you join the trial, you’ll have the opportunity to contribute to important research that may help more women get the screenings they need for early detection of cervical cancer.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with age 30-65 years; for arm A women \> 65 years are allowed
• • Women live in the Czech Republic.
• • Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
• • Women with completed informed consent.
• • Women capable of self-sampling of cervicovaginal swab.
• Exclusion Criteria:
• • Pregnant women.
• • Women with no sexual intercourse experience.
• • Women after hysterectomy including cervix.